Global Pet DNA Vaccines Market Research Report - Segmented by Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Others), By Product (Inactivated, Live Attenuated, Recombinant, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15409
Format:
Region: Global
Chapter 1. Pet DNA Vaccines Market - Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Pet DNA Vaccines Market - Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. Pet DNA Vaccines Market - Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. Pet DNA Vaccines Market - Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. Pet DNA Vaccines Market - Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Pet DNA Vaccines Market - By Animal
6.1 Companion
6.2 Livestock
Chapter 7. Pet DNA Vaccines Market - By Route of Administration
7.1 Oral
7.2 Parenteral
7.3 Others
Chapter 8. Pet DNA Vaccines Market - By Product
8.1 Inactivated
8.2 Live Attenuated
8.3 Recombinant
8.4 Others
Global Pet DNA Vaccines Market - By Distribution Channel
9.1 Veterinary Hospitals
9.2 Veterinary Clinics
9.3 Pharmacies & Drug Stores
9.4 Others
Chapter 9. Pet DNA Vaccines Market – By Region
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Latin America
10.5 The Middle East
10.6 Africa
Chapter 10. Pet DNA Vaccines Market – Key players
11.1 Elanco
11.2 HIPRA
11.3 Boehringer Ingelheim International GmbH
11.4 Virbac
11.5 MSD Animal Health
11.6 Zoetis
11.7 Ceva
11.8 NEOGEN CORPORATION
11.9 Hester Biosciences Limited
11.10 Biogénesis Bag6
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The animals are exposed to several disease-causing hazards because of various internal and external causes, such as disease-causing substances. The injection of veterinary vaccinations is one of the most important methods for avoiding infections in animals.
The Global Pet DNA Vaccines Market was estimated to be worth USD 12.2 billion in 2022 and is projected to reach a value of USD 19.74 billion by 2030, growing at a CAGR of 6.2% during the forecast period 2023-2030.
Increased Awareness and Innovation of New Inoculation Products and Rising Demand for Advanced and Effective Immunization Products are driving the growth of the Global Pet DNA Vaccines Market.
Absence of vaccination Smallholder farmer adoption in developing nations might impede market expansion.
The oral route of administration is the fastest growing in the Global Pet DNA Vaccines Market.
